Categories: Patient Care

American Museum of Natural History video features research of Burchard

A new video produced by the American Museum of Natural History features the work of Esteban Burchard, MD, MPH, and members of his laboratory.

“Genes and Health: Moving Beyond Race,” shows how Burchard’s lab is using differences in the ancestry of asthma patients to help find genetic variations...

Child’s illness fuels lab team’s search for early-life epilepsy diagnostics

The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases. Recently, researchers there have begun applying that focus to seeking a genetic basis and diagnosis for an epilepsy of early...

Artificial kidney project led by Roy cited at White House panel

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with...

Artificial kidney project led by Roy chosen for accelerated FDA program

The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).

Consortium inventing medical devices for children gets new funding

A two-year-old, cross-disciplinary effort to invent new medical devices for children, co-founded by bioengineer Shuvo Roy, PhD, has received a two-year $1 million grant from the U.S. Food and Drug Administration (FDA) to expand its work.

Drugs screened for effects on key transporters, risk of dangerous interactions

To reduce the risk of toxic drug interactions, UCSF's Kathy Giacomini, PhD, and colleagues are screening thousands of prescription drugs, testing how much they inhibit key proteins in kidney and liver cells that help clear medications from the body.

Nelson and Ferrone explain how they are joining forces against prostate cancer

Magnetic resonance imaging (MRI), used with a novel pyruvate chemical compound that is specially labeled to be read by the MRI machine, is being applied for the first time in humans to study the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies.

Imaging lab translates work to patient care

Research under way at UCSF's Margaret Hart Surbeck Laboratory for Advanced Imaging applies powerful, non-invasive equipment to better understand disease and improve disease treatments. "Our overall focus is to develop new imaging techniques and apply basic engineering to biology- and disease-...

UCSF School of Pharmacy sets 5-year plan in motion

Strategic Course 2007-2012

Pages